摘要
目的观察步长稳心颗粒联合胺碘酮治疗室性期前收缩的临床疗效及安全性。方法将78例室性期前收缩患者随机分为治疗组和对照组。治疗组40例，予以步长稳心颗粒加胺碘酮治疗；对照组38例，单用胺碘酮治疗。观察两组患者治疗前后临床症状、室性期前收缩改善情况及不良反应。结果治疗组总有效率92．50％，对照组总有效率78．94％，两组差异有统计学意义（P〈0．05）。结论步长稳心颗粒联合胺碘酮治疗室性期前收缩可以显著提高治疗效果，无明显毒副作用，值得临床推广。
Objective To evaluate the therapeutic efficacy and safety of Wenxin Particle combined with ami- odarone in the treatment of premature ventricular beats. Methods 78 cases with premature ventricular beats were di- vided into observation group （ n = 40 ） and control group （ n = 38 ）. The observation group was treated with Wenxin Particle and amiodarone, the control group was treated amiodarone with only. The improvement of clinical symptoms and premature ventricular beats and the side effects were observed. Results Total effective rate was 78.94% in con- trol group,92.50% in observation group. There was a significantly statistical difference between two groups （P 〈 O. 05 ）. Conclusion Wenxin Particle combined with amiodarone in treating premature ventricular beats can improve the clinical effect and have no obvious side effect, so it is worth being used widely.
出处
《中国基层医药》
CAS
2012年第22期3385-3386,共2页
Chinese Journal of Primary Medicine and Pharmacy
关键词
步长稳心颗粒
胺碘酮
室性期前收缩
Wenxin Particle
Amiodarone
Premature Ventricular Beats
